Publications by authors named "Libby Black"

Claim this Profile
B
Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate-Severe Postoperative Pain.
John A Carter, Libby K Black, Kathleen L Deering, Jonathan S Jahr

Adv Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study.
Richard D Berkowitz, Richard Steinfeld, Alexander P Sah, Vamshi Ruthwik Anupindi, Drishti Shah, Libby K Black

J Pain Palliat Care Pharmacother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.
Richard D Berkowitz, Richard Steinfeld, Alexander P Sah, Randall J Mack, Stewart W McCallum, Libby K Black

Pain Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative intravenous meloxicam for moderate-to-severe pain in the immediate post-operative period: a Phase IIIb randomized clinical trial in 55 patients undergoing primary open or laparoscopic colorectal surgery with bowel resection and/or anastomosis.
Jennifer D Silinsky, Jorge E Marcet, Vamshi Ruthwik Anupindi, Swapna U Karkare, Drishti R Shah, Libby K Black

Pain Manag· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis.
John A Carter, Libby K Black, Dolly Sharma, Tarun Bhagnani, Jonathan S Jahr

BMC Anesthesiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of hospitalization for common neonatal morbidities in preterm and term infants: assessing the impact of one or more major congenital anomalies.
Janet R Hardy, Jeanne M Pimenta, Shibani Pokras, Harish Sehdev, Samantha St Laurent, Libby Black

J Perinatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of morbidities and health-care utilisation in children born following preterm labour compared with full-term labour: A population-based study.
Eline Houben, Elisabeth Smits, Jeanne M Pimenta, Libby K Black, Irene D Bezemer

J Paediatr Child Health· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Cost of Prematurity by Week of Gestational Age.
Eileen M Walsh, Sherian X Li, Libby K Black, Michael Kuzniewicz

AJP Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience of Symptoms and Disease Impact in Patients with Adenomyosis.
Linda M Nelsen, William R Lenderking, Robin Pokrzywinski, Zaneta Balantac, Libby Black

Patient· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Admissions for Preterm Labor.
Michael W Kuzniewicz, Libby Black, Eileen M Walsh, Sherian X Li, Mara Greenberg

AJP Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Hospital Costs Associated With Comorbidities of Prematurity.
Libby Black, Thomas Hulsey, Kwan Lee, Daniel C Parks, Myla D Ebeling

Manag Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Illness in Prostate Cancer Patients with a Low-to-Moderate Risk of Progression: A One-Year, Pan-European Observational Study.
Cesare Selli, Anders Bjartell, Javier Burgos, Matthew Somerville, Juan-Manuel Palacios, Libby Black

Prostate Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
Rajesh Shinghal, Allison Barnes, Kelly M Mahar, Brendt Stier, Lisa Giancaterino, Libby Black

J Sex Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial.
Claus G Roehrborn, Timothy H Wilson, Libby K Black

J Urol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial.
Truls E Bjerklund Johansen, Timothy M Baker, Libby K Black

BJU Int· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
Neil E Fleshner, M Scott Lucia, Blair Egerdie, Lorne Aaron, Gregg Eure, Libby Black

Lancet· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime economic burden of prostate cancer.
Michael E Stokes, Jack Ishak, Irina Proskorovsky, Libby K Black, Yijian Huang

BMC Health Serv Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
Claus G Roehrborn, J Curtis Nickel, Gerald L Andriole, R Paul Gagnier, Libby Black

Urology· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trial.
Michael W Kattan, Stephanie R Earnshaw, Cheryl L McDade, Libby K Black, Gerald L Andriole

Appl Health Econ Health Policy· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of prostate cancer.
Claus G Roehrborn, Libby K Black

BJU Int· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
Kevin Rice, Jane Hudak, Kimberly Peay, Sally Elsamanoudi, Judith Travis, Libby Black

Urology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations.
Stephanie R Earnshaw, Cheryl L McDade, Libby K Black, Christopher F Bell, Michael W Kattan

Pharmacoeconomics· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Richard Olivier Fourcade, Agnes Benedict, Libby K Black, Michael E Stokes, Antonio Alcaraz

BJU Int· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms.
Libby Black, Alyson Grove, Betsy Morrill

Health Qual Life Outcomes· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
Jack Barkin, Claus G Roehrborn, Paul Siami, Olivier Haillot, Betsy Morrill, Libby Black

BJU Int· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis